Aclarion, Inc. (ACONW)
- Previous Close
0.0260 - Open
0.0260 - Bid --
- Ask --
- Day's Range
0.0260 - 0.0279 - 52 Week Range
0.0260 - 0.0279 - Volume
3,200 - Avg. Volume
-- - Market Cap (intraday)
-- - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-6.5760 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Aclarion, Inc., a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States. It develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was incorporated in 2008 and is based in Broomfield, Colorado.
www.aclarion.comRecent News: ACONW
Compare To: ACONW
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ACONW
Valuation Measures
Market Cap
--
Enterprise Value
--
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-113.41%
Return on Equity (ttm)
-655.74%
Revenue (ttm)
75.4k
Net Income Avi to Common (ttm)
-4.91M
Diluted EPS (ttm)
-6.5760
Balance Sheet and Cash Flow
Total Cash (mrq)
1.02M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-1.1M
Company Insights: ACONW
ACONW does not have Company Insights